Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

The role of dose density in combination cancer chemotherapy

Full text
Author(s):
Lopez, Alvaro G. [1] ; Iarosz, Kelly C. [2] ; Batist, Antonio M. [3] ; Seoane, Jesus M. [1] ; Viana, Ricardo L. [4] ; Sanjuan, Miguel A. F. [1]
Total Authors: 6
Affiliation:
[1] Univ Rey Juan Carlos, Dept Fis, Madrid - Spain
[2] Univ Sao Paulo, Inst Phys, Sao Paulo, SP - Brazil
[3] Univ Estadual Ponta Grossa, Dept Math & Stat, Ponta Grossa, PR - Brazil
[4] Univ Fed Parana, Dept Phys, Curitiba, Parana - Brazil
Total Affiliations: 4
Document type: Journal article
Source: COMMUNICATIONS IN NONLINEAR SCIENCE AND NUMERICAL SIMULATION; v. 79, DEC 2019.
Web of Science Citations: 0
Abstract

A multicompartment mathematical model is presented with the goal of studying the role of dose-dense protocols in the context of combination cancer chemotherapy. Dose-dense protocols are intended to reduce the period between courses of chemotherapy from three to two weeks or less, in order to avoid the regrowth of the tumor during the meantime and achieve maximum cell kill at the end of the treatment. Inspired by clinical trials, we carry out a randomized computational study to systematically compare a variety of protocols using two drugs of different specificity. Our results suggest that cycle specific drugs can be administered at low doses between courses of treatment to arrest the relapse of the tumor. This might be a better strategy than reducing the period between cycles. (C) 2019 Elsevier B.V. All rights reserved. (AU)

FAPESP's process: 18/03211-6 - Non linear dynamics
Grantee:Iberê Luiz Caldas
Support type: Research Projects - Thematic Grants
FAPESP's process: 15/07311-7 - Dynamic behaviour of neural networks
Grantee:Kelly Cristiane Iarosz
Support type: Scholarships in Brazil - Post-Doctorate